Clinical Trial Update: Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1

View source ↗

Summary

This clinical trial update discusses evaluating plasma-based analysis for diagnosing and monitoring neurofibromatosis type 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Snippet

Sponsor: Juha Peltonen | Conditions: Neurofibromatosis 1 | Status: UNKNOWN